1 |
De Clercq E, Jiang Y, Li G. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. Travel Med Infect Dis 2022;52:102528. [PMID: 36539022 DOI: 10.1016/j.tmaid.2022.102528] [Reference Citation Analysis]
|
2 |
Yue T, Xu M, Cai T, Zhu H, Pourkarim MR, De Clercq E, Li G. Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period. Front Public Health 2022;10:956712. [PMID: 36091549 DOI: 10.3389/fpubh.2022.956712] [Reference Citation Analysis]
|
3 |
Li G, Wang Y, De Clercq E. Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharm Sin B 2022;12:1567-90. [PMID: 35847492 DOI: 10.1016/j.apsb.2021.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
4 |
Li G, De Clercq E. A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021). Med Res Rev 2021. [PMID: 34636044 DOI: 10.1002/med.21858] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
5 |
Miao M, Clercq E, Li G. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 2021;9:412. [PMID: 33920487 DOI: 10.3390/biomedicines9040412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
6 |
Fical L, Khalikova M, Kočová Vlčková H, Lhotská I, Hadysová Z, Vokřál I, Červený L, Švec F, Nováková L. Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes. Molecules 2021;26:2123. [PMID: 33917128 DOI: 10.3390/molecules26082123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|